🔬Interesting new study: Researchers exposed lab-grown human muscle tissues to blood serum from people with ME/CFS and Long COVID.
After 48 muscles:
- Produced less force
- Fatigued faster
- Lost their ability to hold peak strength
Let’s breakdown the full paper 🧵
Cohort: 4 ME/CFS patients, 5 Long COVID patients, 4 healthy controls (all female).
Method: Researchers grew 3D muscle tissues from human cells, exposed them to patient serum for 48–144h, and tested strength, gene activity (using RNA-seq), structure, and metabolism.
Muscles treated with ME/CFS serum were generally weaker.
Muscles treated with Long COVID serum crashed sooner and couldn’t maintain strength after hitting their peak.
This early fatigue pattern supports what many patients report, myself included.
Researchers then looked at gene activity (transcriptomics), using RNA sequencing in the muscles to find out why this weakness happened.
Both ME/CFS and Long COVID changed hundreds of genes compared to healthy serum.
We are doing whole blood RNA sequencing at @amaticahealth
Will be interesting to see if blood shows similar changes as muscles and how they also vary.
We will also be hoping to do muscle biopsy RNA sequencing in the future via grant funding and will take patients from our RNA whole blood cohort to have both sets of data.
Video explainer on what RNA, RNA Sequencing & Gene expression is on our website:
ME/CFS serum increased activity of genes related to:
- Protein production
- Muscle structure
- Extracellular matrix (the “scaffolding” around cells)
But it reduced genes involved in energy production and general metabolism.
Long COVID serum also increased protein production genes, but showed stronger activation of:
- Mitochondrial structure
- Fatty acid metabolism
- Electron transport chain (for energy production)
It also reduced genes for normal cellular functions.
This suggests:
- ME/CFS muscles prioritize structure, possibly trying to repair or reinforce themselves.
- Long COVID muscles activate energy systems more, possibly trying to fuel themselves under stress.
A key energy-regulating gene, PDK4, went up in both conditions. It shifts energy use from glucose toward fats.
This is usually a stress response.
Glycolysis genes (like ENO3) also increased = more glucose breakdown for quick energy.
Calcium-handling genes were altered:
- More calcium was being pulled into storage inside the cell
- Less calcium was being pumped out
This imbalance can stress mitochondria and cause fatigue.
At the same time, antioxidant defenses were lower. A key enzyme called SOD2, which clears damaging molecules in mitochondria, went down.
That suggests more oxidative stress, which can further damage muscle.
Muscle growth-related genes like FHL1 were up.
This, along with larger muscle fiber diameter, shows the tissue was trying to compensate by growing or strengthening.
This was confirmed by microscope imaging.
The mitochondria (the cell’s energy producers) also changed.
Instead of their normal shape, they became highly fused and elongated, forming large networks.
This is a common stress response to increase energy efficiency.
Researchers measured real-time energy use in the cells.
Both ME/CFS and Long COVID muscles consumed more oxygen than controls.
But ME/CFS muscles had the highest energy use of all.
In ME/CFS tissues:
- Baseline oxygen consumption was highest
- Proton leak (wasted oxygen use) was highest
- Glycolysis (non-oxygen energy pathway) also increased
This shows heavy energy strain.
In Long COVID tissues:
- Some energy markers went up
- But more oxygen was used by non-mitochondrial processes (likely inflammation or oxidative stress)
This means the mitochondria were less involved in energy production.
In short:
ME/CFS muscles pushed all systems harder (both mitochondrial and glycolytic)
Long COVID muscles tried to adapt, but energy use was less efficient.
Possibly due to Long COVID being earlier into the process?
What happens if exposure to patient serum continues?
Researchers ran long-term tests (up to 144 hours).
The muscles began to fail.
By day 4-6:
- Muscle tissues got thinner
- Mitochondria broke apart into small, dysfunctional fragments
- Some mitochondria turned into ring shapes, a sign of severe damage
- Force production collapsed
This shows the muscles entered a second phase:
From early adaptation (trying to compensate) to collapse (losing structure and function).
This mirrors what happens in patients with long-term fatigue and muscle issues.
Key takeaway:
The blood of ME/CFS and Long COVID patients contains factors that directly damage muscle, even without any exercise.
This damage is not due to inactivity. It is driven by circulating biological signals.
These findings support patient reports of:
- Muscle weakness
- Exertion intolerance
- Fatigue after light activity
- Long-term muscle loss
All of this was reproduced in a controlled lab model.
While both ME/CFS and Long COVID had similar effects, there were differences:
- ME/CFS caused more metabolic overdrive
- Long COVID had more uncoupled, inefficient energy use
- ME/CFS showed more structural remodeling
We will be measuring all genes mentioned above in whole blood, very interested to see the findings in patients with muscle weakness like myself. To join:
🔬New study shows SARS-CoV-2 causes direct damage to heart cell mitochondria - even months after recovery - helping potentially explain Long COVID heart symptoms like chest pain, palpitations & fatigue.
Been waiting to have time to read this paper. Let’s break it down. 🧵
Researchers studied 5 people who had COVID-19 weeks or months earlier. They all had new or unusual heart problems, like chest pain, irregular heartbeat, or even cardiac arrest.
Each patient had a heart biopsy (a sample of heart tissue examined under a microscope).
All 5 patients were diagnosed with myocarditis - inflammation and injury in heart muscle.
But interestingly, it wasn’t typical myocarditis with large immune cell infiltration. Inflammation was mild.
The key problem? Structural damage inside the heart muscle cells.
Many new faces, so I thought I’d share my story and how @amaticahealth came to be.
I developed Long COVID in 2021 after a Delta infection, almost immediately experiencing neurological symptoms like vertigo and visual snow syndrome (VSS).
My condition worsened rapidly after my physician recommended intense exercise, leading to a major crash from which I never recovered.
Before Long COVID, I studied aerospace engineering at the University of Manchester and did extracurricular projects on satellite and lunar rover design.
I also produced music under the name Roy Next Door (feel free to check out my music on Spotify 😁).
🔬New @BhupeshPrusty paper breakdown - very cool paper:
The study finds that people with ME/CFS & Long COVID have antibodies in their blood that may directly interfere with mitochondria (how human cells create energy and regulate inflammation)
In simple language all findings 🧵
So some basic knowledge first:
Our immune systems make antibodies (also called IgG). These are proteins that help the body fight off infections.
In some people, antibodies don’t shut off properly and may begin to affect the body’s own cells. This is called autoimmunity.
Prusty’s team took IgG antibodies from people with ME/CFS, Long COVID, Multiple Sclerosis (MS - another seperate disease), and healthy people.
They added these antibodies to lab-grown human cells to see what happens inside the cells.
RABGAP1L is a protein that helps control how cells move and recycle materials. It turns off other proteins that guide tiny packages inside the cell. These packages carry waste, used-up parts, or germs to places where they can be broken down.
How it fights infection:
By turning Rab proteins off at the right time, RABGAP1L moves invading bacteria and viruses into compartments where they are broken down. Loss or reduction of RABGAP1L lets more influenza virus and Streptococcus pyogenes survive and replicate in cells.
Laboratory evidence:
- Cells lacking RABGAP1L show higher viral entry and larger numbers of autophagic (recycling) vesicles.
- Restoring RABGAP1L reverses these changes.
- Genome-wide CRISPR screens list RABGAP1L among top antiviral host factors.